Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review Angela LisibachValérie BenelliMonika Lutters Review Open access 03 October 2020 Pages: 147 - 162
Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride Stefanie FeketeK. EgbertsM. Gerlach Clinical Trial Open access 28 September 2020 Pages: 163 - 170
Benzodiazepine withdrawal in older people: what is the prevalence, what are the signs, and which patients? Alexandra JobertEdouard-Jules LaforgueCaroline Victorri-Vigneau Clinical Trial 02 October 2020 Pages: 171 - 177
A real or apparent decrease in glomerular filtration rate in patients using olaparib? M. A. C. BruinC. M. KorseA. D. R. Huitema Pharmacodynamics Open access 14 December 2020 Pages: 179 - 188
Effects of a multifaceted intervention to promote the use of intravenous iron sucrose complex instead of ferric carboxymaltose in patients admitted for more than 24 h Justine TouchardG. PerrinB. Sabatier Pharmacoeconomics 14 September 2020 Pages: 189 - 195
Monte Carlo simulation evaluation of tigecycline dosing for bacteria with raised minimum inhibitory concentrations in non-critically ill adults Brianna KispalSandra A. N. Walker Pharmacokinetics and Disposition 25 September 2020 Pages: 197 - 205
Ceftriaxone dosing in patients admitted from the emergency department with sepsis Aaron J. HeffernanRebecca A. CurranJeffrey Lipman Pharmacokinetics and Disposition 24 September 2020 Pages: 207 - 214
Impact of age and CYP2D6 genotype on exposure of zuclopenthixol in patients using long-acting injectable versus oral formulation—an observational study including 2044 patients Marit TveitoRobert Løvsletten SmithGudrun Høiseth Pharmacokinetics and Disposition 30 September 2020 Pages: 215 - 221
Evaluation of iberdomide and cytochrome p450 drug-drug interaction potential in vitro and in a phase 1 study in healthy subjects Allison GaudyChristian AtsrikuMaria Palmisano Pharmacokinetics and Disposition 23 September 2020 Pages: 223 - 231
Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis Milo GattiEmanuel RaschiFabrizio De Ponti Pharmacoepidemiology and Prescription Open access 08 September 2020 Pages: 233 - 239
Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia Damiana ScuteriMarilù VulneraMaria Tiziana Corasaniti Pharmacoepidemiology and Prescription Open access 15 September 2020 Pages: 241 - 249
What should patients do if they miss a dose? A systematic review of patient information leaflets and summaries of product characteristics Abdullah AlbassamDyfrig A. Hughes Pharmacoepidemiology and Prescription Open access 29 September 2020 Pages: 251 - 260
Re-recognizing bromhexine hydrochloride: pharmaceutical properties and its possible role in treating pediatric COVID-19 Qibo FuXiao ZhengShaoqing Ni Letter to the Editor 01 September 2020 Pages: 261 - 263
Iron chelation may harm patients with COVID-19 Michael D. GarrickAndrew J. Ghio Letter to the Editor 01 September 2020 Pages: 265 - 266
Reply: Iron chelation may harm patients with COVID-19 Anis Abobaker Letter to the Editor 01 September 2020 Pages: 267 - 268
Triptan overuse during pregnancy: a possible cause of placental hypoperfusion Delphine ViardAlexandre GérardMilou-Daniel Drici Letter to the Editor 04 September 2020 Pages: 269 - 270
Visual snow syndrome after start of citalopram—novel insights into underlying pathophysiology Ozan E. ErenFlorian SchöberlAndreas Straube Letter to the Editor Open access 16 September 2020 Pages: 271 - 272
Correction to: Optimization of infliximab therapy in inflammatory bowel disease using a dashboard approach—an Indian experience Mihika B. DaveAlpa J. DheraiTester F. Ashavaid Correction 04 September 2020 Pages: 273 - 274